<> Jubilant Pharmova Share Price Today: Live Jubilant Pharmova Share Price NSE/BSE | 5paisa
JUBLPHARMA

Jubilant Pharmova Share PriceJubilant Pharmova

₹342.00
-6.1 (-1.75%)
  • Advice
  • Hold
As on 05 February, 2023 | 20:04 BSE: 530019 NSE: JUBLPHARMA

Jubilant Pharmova Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Jubilant Pharmova

Start SIP

Jubilant Pharmova Share Price

  • Over 1 Month -4.97%
  • Over 3 Month -7.32%
  • Over 6 Month -1.74%
  • Over 1 Year -34.78%

Jubilant Pharmova Key Statistics

P/E Ratio 56.4
PEG Ratio -0.7
Market Cap Cr 5,447
Price to Book Ratio 1
EPS 4.9
Dividend 1.5
Relative Strength Index 39.09
Money Flow Index 48.83
MACD Signal -7.34
Average True Range 15.48

Jubilant Pharmova Investment Rating

  • Master Rating:
  • Jubilant Pharmova has an operating revenue of Rs. 6,118.17 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 10% is healthy, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 46%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 17 which is a POOR score indicating inconsistency in earnings, a RS Rating of 24 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 107 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Jubilant Pharmova Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 18321520029
Operating Expenses Qtr Cr 18521620930
Operating Profit Qtr Cr -27-4-2
Depreciation Qtr Cr 121192
Interest Qtr Cr 6438
Tax Qtr Cr -56-1-1
Net Profit Qtr Cr -692-5-3

Jubilant Pharmova Technicals

EMA & SMA

Current Price
₹342.
-6.1 (-1.75%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 353.66
  • 50 Day
  • 362.56
  • 100 Day
  • 366.22
  • 200 Day
  • 390.89
  • 20 Day
  • 353.32
  • 50 Day
  • 371.87
  • 100 Day
  • 361.51
  • 200 Day
  • 368.57

Jubilant Pharmova Resistance and Support

PIVOT
₹350.19
Resistance
First Resistance 356.57
Second Resistance 365.04
Third Resistance 371.42
RSI 39.1
MFI 48.83
MACD Single Line -7.34
MACD -7.36
Support
First Resistance 341.72
Second Resistance 335.34
Third Resistance 326.87

Jubilant Pharmova Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 466,995 10,353,279 22.17
Week 172,446 5,364,801 31.11
1 Month 92,763 3,722,568 40.13
6 Month 252,457 9,093,493 36.02

Jubilant Pharmova Result Highlights

Jubilant Pharmova Synopsis

NSE-Medical-Diversified

Jubilant Pharmova is involved in the business activities of Manufacture of basic chemicals. Company’s Total Operating Revenue is Rs. 87.75 Cr. and Equity Capital is Rs. 15.93 Cr. for the Year ended 31/03/2022. Jubilant Pharmova Ltd. is a Public Limited Listed company incorporated on 21/06/1978 and has its registered office in the State of Uttar Pradesh, India. Company’s Corporate Identification Number(CIN) is L24116UP1978PLC004624 and registration number is 004624.
Market Cap 5,474
Sales 639
Shares in Float 7.80
No of funds 150
Yield 1.45
Book Value 4.27
U/D Vol ratio 1.2
LTDebt / Equity 39
Alpha -0.12
Beta 0.82

Jubilant Pharmova

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 50.68%50.68%50.68%
Mutual Funds 0.4%0.39%0.04%
Foreign Portfolio Investors 23.38%23.06%23.47%
Financial Institutions/ Banks
Individual Investors 18.68%19%19.35%
Others 6.86%6.87%6.46%

Jubilant Pharmova Management

Name Designation
Mr. Shyam S Bhartia Chairman
Mr. Hari S Bhartia Co-Chairman & Manag. Director
Mr. R Kumar Whole Time Director
Mr. Arvind Chokhany Whole Time Director
Mr. Arun Seth Independent Director
Mr. Priyavrat Bhartia Director
Mr. Arjun Shanker Bhartia Director
Mr. Vivek Mehra Independent Director
Mr. Sushil Kumar Roongta Independent Director
Ms. Sudha Pillai Independent Director
Dr. Ashok Misra Independent Director
Mr. S Sridhar Independent Director

Jubilant Pharmova Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Jubilant Pharmova Corporate Action

Date Purpose Remarks
2023-02-03 Quarterly Results
2022-10-21 Quarterly Results
2022-08-02 Quarterly Results
2022-05-27 Audited Results & Final Dividend
2022-02-04 Quarterly Results
Date Purpose Remarks
2022-08-12 FINAL Rs.5.00 per share(500%)Final Dividend
2021-08-06 FINAL Rs.5.00 per share(500%)Final Dividend

Jubilant Pharmova MF Shareholding

Name Amount(cr)
Nippon India Pharma Fund - Growth 4563
Nippon India Nifty Smallcap 250 Index Fund Reg Gr 397
Motilal Oswal Nifty 500 Fund Regular Growth 380
Motilal Oswal Nifty Smallcap 250 Index Fund Regular Growth 320
SBI Nifty Smallcap 250 Index Fund Regular Growth 146

Jubilant Pharmova FAQs

What is Share Price of Jubilant Pharmova ?

Jubilant Pharmova share price is ₹342 As on 05 February, 2023 | 19:50

What is the Market Cap of Jubilant Pharmova ?

The Market Cap of Jubilant Pharmova is ₹5447.4 Cr As on 05 February, 2023 | 19:50

What is the P/E ratio of Jubilant Pharmova ?

The P/E ratio of Jubilant Pharmova is 56.4 As on 05 February, 2023 | 19:50

What is the PB ratio of Jubilant Pharmova ?

The PB ratio of Jubilant Pharmova is 1 As on 05 February, 2023 | 19:50

Q2FY23